What is Shanghai Haohai Biological Technology Co Revenue per Share?
Shanghai Haohai Biological Technology Co's revenue per share for the
three
months ended in Dec. 2024 was ¥2.60.
Shanghai Haohai Biological Technology Co's revenue per share for the trailing twelve months (TTM) ended in Dec. 2024 was ¥11.42.
Warning Sign:
Shanghai Haohai Biological Technology Co Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Shanghai Haohai Biological Technology Co was 1.10% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 12.20% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 13.20% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 12.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
SHSE:688366'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -3.8 Med: 17.2 Max: 26.4
Current: 12.2
During the past 11 years, Shanghai Haohai Biological Technology Co's highest 3-Year average Revenue Per Share Growth Rate was 26.40% per year. The lowest was -3.80% per year. And the median was 17.20% per year.
SHSE:688366's 3-Year Revenue Growth Rate is ranked better than 66.88% of 791
companies
in the Biotechnology industry
Industry Median: 1
vs SHSE:688366: 12.20
Shanghai Haohai Biological Technology Co Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shanghai Haohai Biological Technology Co Revenue per Share Chart
Shanghai Haohai Biological Technology Co Annual Data
Competitive Comparison of Shanghai Haohai Biological Technology Co's Revenue per Share
For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Haohai Biological Technology Co's PS Ratio Distribution in the Biotechnology Industry
Shanghai Haohai Biological Technology Co Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Haohai Biological Technology Co (SHSE:688366) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Shanghai Haohai Biological Technology Co Revenue per Share Related Terms
Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Haohai Biological Technology Co Business Description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688366 has been successfully added to your 